Recent sequencing of these tumors demonstrated that 90% of poromas and ~70% of porocarcinomas exhibit YAP1 or WWTR1 gene fusions, with YAP1 fused to either MAML2 or NUTM1 and WWTR1 fused to NUTM1. The gene discussed is MAML2; the disease is eccrine porocarcinoma.